Skip to content
Catalyst

glyphosateWhat was measured

Measured, with no finding

339 endpoints

Show what was measuredHide what was measured
  • 8-hydroxydeoxyguanosine (8-OHdG) in blood DNA, correlation with GBF exposure frequency

    no effect

    A statistically significant exposure frequency correlation was not observed for GBF exposure.

    PMID 25687244 · one of two readings recorded this

  • Binucleated micronucleated cell (BNMN) frequency, self-reported spray exposure vs none

    no effect

    For all three sprayed regions, there was no statistically significant difference in BNMN frequency between those self-reporting spraying exposure and those self-reporting no spraying exposure.

    PMID 25687244 · one of two readings recorded this

  • Blood cell comet DNA migration (tail length), exposed vs non-exposed

    increases

    The study reported increases in damaged cell categories and statistically significant increases in DNA migration (tail length) in the presumably exposed population.

    PMID 25687244 · one of two readings recorded this

  • BNMN frequency immediately post-spraying vs pre-spraying

    increases

    The publication reported a small statistically significant increase in the frequency of BNMN in samples collected from people living in three regions within 5 days after spraying of GBFs

    PMID 25687244 · one of two readings recorded this

  • BNMN frequency in floriculturists vs referent population

    no effect, n = 51

    One of these studies reported no statistically significant increase in BNMN frequency compared to a referent population for the CBMN endpoint in a population of 51 floriculturists of whom 21 reported GBF use

    PMID 25687244 · one of two readings recorded this

  • Chromosomal alteration and chromosomal fragility, 2 years after last aerial spraying

    no effect, n = 92

    The exposed population used for genomic and chromosome analysis (92 individuals) and the referent sample population (90 individuals) were much larger than those of the previous study

    PMID 25687244 · one of two readings recorded this

  • B-cell lymphoma risk

    increases

    | Model 1 | B-cell lymphoma | 3, 8 | 2.0 | 1.1–3.6 | 0.0% | 0.58 |

    PMID 27015139 · one of two readings recorded this

  • B-cell lymphoma risk

    no effect

    8 | Cocco et al. | 2013 | B-cell lymphoma | 4 cases, 2 controls | 3.1 | 0.6–17.1 | | |

    PMID 27015139 · one of two readings recorded this

  • B-cell lymphoma risk

    unclear

    3 | Eriksson et al. | 2008 | B-cell lymphoma | Not reported | 1.87 | 0.998–3.51 | | |

    PMID 27015139 · one of two readings recorded this

  • chronic lymphocytic leukemia/small lymphocytic lymphoma risk

    no effect

    | Model 1, fixed effects | CLL/SLL | 3, 7 | 1.9 | 0.9–4.0 | | |

    PMID 27015139 · one of two readings recorded this

  • chronic lymphocytic leukemia/small lymphocytic lymphoma risk

    no effect

    | Model 1, random effects | CLL/SLL | 3, 7 | 1.3 | 0.2–10.0 | 83.7% | 0.01 |

    PMID 27015139 · one of two readings recorded this

  • chronic lymphocytic leukemia/small lymphocytic lymphoma risk

    increases

    3 | Eriksson et al. | 2008 | CLL/SLL | Not reported | 3.35 | 1.42–7.89 | | |

    PMID 27015139 · one of two readings recorded this

  • chronic lymphocytic leukemia/small lymphocytic lymphoma risk

    no effect

    7 | Orsi et al. | 2009 | CLL/SLL | 2 cases, 18 controls | 0.4 | 0.1–1.8 | | |

    PMID 27015139 · one of two readings recorded this

  • diffuse large B-cell lymphoma risk

    no effect

    | Model 1 | Diffuse large B-cell lymphoma | 3, 7 | 1.1 | 0.5–2.3 | 0.0% | 0.79 |

    PMID 27015139 · one of two readings recorded this

  • diffuse large B-cell lymphoma risk

    no effect

    3 | Eriksson et al. | 2008 | Diffuse large B-cell lymphoma | Not reported | 1.22 | 0.44–3.35 | | |

    PMID 27015139 · one of two readings recorded this

  • diffuse large B-cell lymphoma risk

    no effect

    7 | Orsi et al. | 2009 | Diffuse large B-cell lymphoma | 5 cases, 24 controls | 1.0 | 0.3–2.7 | | |

    PMID 27015139 · one of two readings recorded this

  • follicular lymphoma risk

    no effect

    | Model 1 | Follicular lymphoma | 3, 7 | 1.7 | 0.7–3.9 | 0.0% | 0.73 |

    PMID 27015139 · one of two readings recorded this

  • follicular lymphoma risk

    no effect

    3 | Eriksson et al. | 2008 | Follicular lymphoma | Not reported | 1.89 | 0.62–5.79 | | |

    PMID 27015139 · one of two readings recorded this

  • follicular lymphoma risk

    no effect

    7 | Orsi et al. | 2009 | Follicular lymphoma | 3 cases, 24 controls | 1.4 | 0.4–5.2 | | |

    PMID 27015139 · one of two readings recorded this

  • hairy-cell leukemia risk

    no effect

    | Model 1 | Hairy-cell leukemia | 7, 9 | 2.5 | 0.9–7.3 | 0.0% | 0.63 |

    PMID 27015139 · one of two readings recorded this

  • hairy-cell leukemia risk

    no effect

    9 | Nordström et al. | 1998 | Hairy-cell leukemia | 4 cases, 5 controls | 3.1 | 0.8–12 | | |

    PMID 27015139 · one of two readings recorded this

  • hairy-cell leukemia risk

    no effect

    7 | Orsi et al. | 2009 | Hairy-cell leukemia | 2 cases, 18 controls | 1.8 | 0.3–9.3 | | |

    PMID 27015139 · one of two readings recorded this

  • Hodgkin lymphoma risk

    no effect

    | Model 1 | Hodgkin lymphoma | 7, 10 | 1.1 | 0.7–1.6 | 0.0% | 0.36 |

    PMID 27015139 · one of two readings recorded this

  • Hodgkin lymphoma risk

    no effect

    Karunanayake et al. | 2012 | Never used glyphosate: 278 cases, 1373 controls Ever used glyphosate: 38 cases, 133 controls | Fully adjusted HL OR = 0.99 Minimally adjusted (age, province) HL OR = 1.14 | Fully adjusted HL 95% CI = 0.62–1.56 Minimally adjusted (age, province) HL 95% CI = 0.74–1.76

    PMID 27015139 · one of two readings recorded this

  • Hodgkin lymphoma risk

    no effect

    10 | Karunanayake et al. | 2012 | Hodgkin lymphoma | 38 cases, 133 controls | 0.99 | 0.62–1.56 | | |

    PMID 27015139 · one of two readings recorded this

  • Hodgkin lymphoma risk

    no effect

    7 | Orsi et al. | 2009 | Hodgkin lymphoma | 6 cases, 24 controls | 1.7 | 0.6–5.0 | | |

    PMID 27015139 · one of two readings recorded this

  • leukemia risk

    no effect

    Brown et al. | 1990 | Non-farmers: 243 cases, 547 controls Ever mixed, handled, or applied glyphosate: 15 cases, 49 controls | Leukemia OR = 0.9 | Leukemia 95% CI = 0.5–1.6

    PMID 27015139 · one of two readings recorded this

  • leukemia risk

    no effect

    Kaufman et al. | 2009 | No glyphosate use: 179 cases, 753 controls Glyphosate: 1 case, 3 controls | Crude leukemia OR = 1.40 | Crude leukemia 95% CI = 0.15–13.56

    PMID 27015139 · one of two readings recorded this

  • multiple myeloma risk

    no effect

    Pahwa et al. | 2012 | Never used glyphosate: 310 cases, 1373 controls Ever used glyphosate: 32 cases, 133 controls | MM OR = 1.22 | MM 95% CI = 0.77–1.93

    PMID 27015139 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    | Model 1 | Non-Hodgkin lymphoma | 1a, 2, 3, 4, 6, 7 | 1.3 | 1.0–1.6 | 0.0% | 0.84 |

    PMID 27015139 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    | Model 2 | Non-Hodgkin lymphoma | 1b, 2, 3, 4, 6, 7 | 1.3 | 1.0–1.6 | 0.0% | 0.59 |

    PMID 27015139 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    | Model 3 | Non-Hodgkin lymphoma | 1a, 2, 3, 4, 5, 7 | 1.3 | 1.0–1.7 | 0.0% | 0.85 |

    PMID 27015139 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    | Model 4 | Non-Hodgkin lymphoma | 1b, 2, 3, 4, 5, 7 | 1.4 | 1.0–1.8 | 0.0% | 0.63 |

    PMID 27015139 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    Cantor et al. | 1992 | Non-farmers: 226 cases, 547 controls Ever handled, mixed, or applied glyphosate: 26 cases, 49 controls | NHL OR = 1.1 | NHL 95% CI = 0.7–1.9

    PMID 27015139 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    Hardell et al. | 2002 | No pesticide exposure: NR Glyphosate exposure for ≥ 1 working day, ≥ 1 year prior to diagnosis or control index date: 8 cases, 8 controls | Multivariate NHL OR = 1.85 Univariate NHL OR = 3.04 | Multivariate NHL 95% CI = 0.55–6.20 Univariate NHL 95% CI = 1.08–8.52

    PMID 27015139 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    1 | De Roos et al. | 2003 | Non-Hodgkin lymphoma | 36 cases, 61 controls | a. 1.6 (hierarchical regression) b. 2.1 (logistic regression) | a. 0.9–2.8 (hierarchical regression) b. 1.1–4.0 (logistic regression) | | |

    PMID 27015139 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    1 | De Roos et al. | 2003 | Non-Hodgkin lymphoma | 36 cases, 61 controls | a. 1.6 (hierarchical regression) b. 2.1 (logistic regression) | a. 0.9–2.8 (hierarchical regression) b. 1.1–4.0 (logistic regression) | | |

    PMID 27015139 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    2 | De Roos et al. | 2005 | Non-Hodgkin lymphoma | 71 cases* | 1.1 | 0.7–1.9 | | |

    PMID 27015139 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    3 | Eriksson et al. | 2008 | Non-Hodgkin lymphoma | 29 cases, 18 controls | 1.51 | 0.77–2.94 | | |

    PMID 27015139 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    4 | Hardell et al. | 2002 | Non-Hodgkin lymphoma | 8 cases, 8 controls | 1.85 | 0.55–6.20 | | |

    PMID 27015139 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    5 | Hohenadel et al. | 2011 | Non-Hodgkin lymphoma | 50 cases, 133 controls | 1.40 (random effects meta-RR) | 0.62–3.15 (random effects meta-CI) | | |

    PMID 27015139 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    6 | McDuffie et al. | 2001 | Non-Hodgkin lymphoma | 51 cases, 133 controls | 1.2 | 0.83–1.74 | | |

    PMID 27015139 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    7 | Orsi et al. | 2009 | Non-Hodgkin lymphoma | 12 cases, 24 controls | 1.0 | 0.5–2.2 | | |

    PMID 27015139 · one of two readings recorded this

  • funnel plot asymmetry, highest exposure and NHL

    no effect, p = 0.851

    Beggs tests (p = 0.851)

    PMID 31342895 · one of two readings recorded this

  • funnel plot asymmetry, highest exposure and NHL

    no effect, p = 0.185

    Eggers (p = 0.185)

    PMID 31342895 · one of two readings recorded this

  • hepatic reduced glutathione

    decreases

    In a study of albino male rats, levels of hepatic reduced glutathione were significantly decreased in GBH-exposed animals (1.64 mmol/g) compared to controls (2.64 mmol/g)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk, Chang and Delzell meta-analysis

    increases

    Chang and Delzell reported a meta-RR of 1.27 (95% CI: 1.01-1.59) in their primary analysis

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk, IARC meta-analysis

    increases

    resulting in a meta-RR of 1.30 (95% CI: 1.03 −1.65)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk, Schinasi and Leon meta-analysis

    increases

    Schinasi and Leon first reported a meta-RR of 1.45 (95% CI: 1.08-1.95)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    the meta-RR was 1.30 (95% CI: 1.03-2.64)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    which contributed to a meta-RR of 1.40 (95% CI: 1.13-1.75)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    we observed a meta-RR of 1.41 (95% CI: 1.13-1.75)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    With the original AHS 2005 cohort results, we observed a meta-RR of 1.45 (95% CI: 1.11–1.91) for NHL

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    (meta-RR = 1.84, 95% CI: 1.33-2.55)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    the resulting RR remained fairly similar at 1.43 (95% CI: 1.15-1.78)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    When Cantor et al. or Lee et al. were used instead of De Roos et al., the meta-RR decreased to 1.29 (95% CI: 1.04-1.59) and 1.35 (95% CI: 1.11-1.65)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    (1.41, 95 % CI: 1.13-1.77

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    the meta-RR increased to 1.46 (1.16-1.83)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    (1.43, 95% CI: 1.14-1.78)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    caused the meta-RR to decrease to 1.23 (95% CI: 0.99-1.53)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    When Cantor et al. or Lee et al. were used instead of De Roos et al., the meta-RR decreased to 1.29 (95% CI: 1.04-1.59) and 1.35 (95% CI: 1.11-1.65)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    (meta-RR = 1.36, 95% CI: 1.09-1.70)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    the meta-RR was 1.36 (95% CI: 1.06-1.75

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    the meta-RRs increased to 1.56 (95% CI: 1.17-2.06)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    the meta-RR remained the same at 1.41 (95% CI: 1.13-1.74)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    meta-RRadjusted = 1.46, 95% CI: 1.05-2.02

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    meta-RRunadjusted = 1.69, 95% CI: 1.29-2.23

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    unclear

    European studies had a meta-RR of 1.53 (95% CI: 0.93-2.52)

    PMID 31342895 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    Studies in North America had a meta-RR of 1.38 (95% CI: 1.08-1.76)

    PMID 31342895 · one of two readings recorded this

  • chronic lymphocytic leukemia/small lymphocytic lymphoma risk

    no effect

    that for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) was 0.85 (95% CI 0.20-1.49, p-het = 0.17; I² = 44%)

    PMID 32096774 · one of two readings recorded this

  • diffuse large B-cell lymphoma risk

    unclear

    reported a RR of 1.36 (95% CI 1.00-1.85) for risk of DLBCL

    PMID 32096774 · one of two readings recorded this

  • diffuse large B-cell lymphoma risk

    unclear

    The meta-RR for diffuse large B-cell lymphoma (DLBCL) was 1.31 (95% CI 0.93-1.7; p-het = 0.85; I² = 0)

    PMID 32096774 · one of two readings recorded this

  • follicular lymphoma risk

    no effect

    that for follicular lymphoma (FL) was 0.82 (95% CI 0.93-1.70, p-het = 0.63; I² = 0)

    PMID 32096774 · one of two readings recorded this

  • funnel plot asymmetry, ever-exposure and NHL

    unclear, p = 0.02

    the result of the Egger’s test (p= 0.02)

    PMID 32096774 · one of two readings recorded this

  • multiple myeloma risk

    no effect

    the meta-RR was 1.04 (95% CI 0.67-1.41; p-het = 0.21; I² = 16%)

    PMID 32096774 · one of two readings recorded this

  • multiple myeloma risk

    no effect

    1.01 (95% CI 0.84-1.19) for MM

    PMID 32096774 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    unclear

    resulted in a meta-RR equal to 1.49 (95% CI 0.37-2.61)

    PMID 32096774 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    RR for the highest quartile, ≥108.5 days, 0.78; 95% CI 0.58-1.05

    PMID 32096774 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    the adjusted OR for more than 10 days/year was 1.51 (95% CI 0.77-2.94)

    PMID 32096774 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    the unadjusted OR was 2.12 (95% CI 1.2-3.7) for more than 2 days/year

    PMID 32096774 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    an association was reported for combined exposure to malathion and glyphosate (OR 2.10; 95% CI 1.31-3.37)

    PMID 32096774 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    but not for exposure to glyphosate alone (OR 0.92; 95% CI 0.54-1.55)

    PMID 32096774 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    The exclusion of this study resulted in a NHL meta-RR equal to 1.27 (95% CI 0.92-1.61)

    PMID 32096774 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    resulted in a meta-RR of 1.03 (95% CI 0.86-1.21; p-value of test for heterogeneity [p-het] = 0.7; I² = 0%)

    PMID 32096774 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    were 1.13 (95% CI 0.88-1.37) for NHL

    PMID 32096774 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    malathion alone (OR 1.95; 95% CI 1.29-2.93)

    PMID 32096774 · one of two readings recorded this

  • diffuse large B-cell lymphoma risk

    increases

    the meta-RR for diffuse large B-cell lymphoma (DLBCL) was 1.29 (95% CI 1.02-1.63)

    PMID 34142676 · one of two readings recorded this

  • funnel plot asymmetry, ever-exposure and NHL

    unclear, p = 0.04

    the result of the Egger’s test (p= 0.04)

    PMID 34142676 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    yielded in a meta-RR equal to 1.15 (95% CI 0.72-1.83)

    PMID 34142676 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    an association was reported for combined exposure to malathion and glyphosate (OR 2.10; 95% CI 1.31-3.37)

    PMID 34142676 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    reduced the OR for ever-exposure to glyphosate from 2.02 (95% CI 1.10-3.71) to 1.51 (95% CI 0.77-2.94)

    PMID 34142676 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    increases

    reduced the OR for ever-exposure to glyphosate from 2.02 (95% CI 1.10-3.71) to 1.51 (95% CI 0.77-2.94)

    PMID 34142676 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    but not for exposure to glyphosate alone (OR 0.92; 95% CI 0.54-1.55)

    PMID 34142676 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    resulted in a meta-RR of 1.21 (95% CI 0.95-1.53; I2 = 0%)

    PMID 34142676 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    The meta-analysis resulted in a meta-RR of 1.05 (95% CI 0.90-1.24; p-value of test for heterogeneity = 0.46; I² = 0%)

    PMID 34142676 · one of two readings recorded this

  • non-Hodgkin lymphoma risk

    no effect

    the corresponding meta-RR for ever-exposure in the same three studies was 1.13 (95% CI 0.77-1.66)

    PMID 34142676 · one of two readings recorded this

  • Composite vs averaged daily urinary glyphosate (one participant)

    no effect

    Week 1 Composite sample=0.349μg/L, Average of seven individual daily samples μg/L=0.350

    PMID 37493357 · one of two readings recorded this

  • Composite vs averaged daily urinary glyphosate (one participant)

    no effect

    Week 2 Composite sample=0.263μg/L, Average of seven individual daily samples=0.262

    PMID 37493357 · one of two readings recorded this

  • Glyphosate detection frequency across all weekly composite samples

    n = 78

    Glyphosate was detected in 74.4% of the 78 total weekly FMV composite urine samples.

    PMID 37493357 · one of two readings recorded this

  • Glyphosate detection frequency, conventional vs organic phase

    unclear

    Among all participants, the detection frequency was 76.9% during the conventional phase and 71.8% during the organic phase.

    PMID 37493357 · one of two readings recorded this

  • Glyphosate detection frequency, conventional vs organic week

    unclear

    among participants living far from fields, glyphosate was detected in 78.9% of the conventional week samples and 68.4% of the samples collected during the organic week

    PMID 37493357 · one of two readings recorded this

  • Glyphosate detection frequency, conventional vs organic week

    no effect

    For near-field participants, the detection frequency was 75% during both weeks

    PMID 37493357 · one of two readings recorded this

  • Median percent change in urinary glyphosate, conventional to organic diet

    no effect, p = 0.18

    Exclude participants missing ≥4 samples from either week c | −17.7 (−37.4, 29.8) | −22.3 (−37.4, −8.8) | 1.4 (−41.9, 43.0) | 0.18 | 0.09 | 0.82

    PMID 37493357 · one of two readings recorded this

  • Median percent change in urinary glyphosate, conventional to organic diet

    decreases, p = 0.04

    Exclude participants missing ≥4 samples or who did not turn in Food Log for either week d | −18.7 (−47.7, 17.5) | −26.8 (−43.1, −16.8) | −11.0 (−47.7, 30.2) | 0.04 | <0.01 | 0.66

    PMID 37493357 · one of two readings recorded this

  • Median percent change in urinary glyphosate, conventional to organic diet

    decreases, p = 0.04

    Exclude participants who did not turn in Food Log for either week c | −19.5 (−42.5, 15.7) | −29.1 (−37.4, −17.0) | −11.0 (−47.7, 30.2) | 0.04 | <0.01 | 0.66

    PMID 37493357 · one of two readings recorded this

  • Median percent change in urinary glyphosate, conventional to organic diet

    no effect, p = 0.17, n = 39

    All participants b | −18.4 (−37.4, 29.8) | −24.2 (−37.4, −8.8) | 1.4 (−41.9, 43.0) | 0.17 | 0.06 | 0.83

    PMID 37493357 · one of two readings recorded this

  • Median percent change in urinary glyphosate, conventional to organic diet

    decreases, p = 0.09

    Exclude participants missing ≥4 samples from either week c | −17.7 (−37.4, 29.8) | −22.3 (−37.4, −8.8) | 1.4 (−41.9, 43.0) | 0.18 | 0.09 | 0.82

    PMID 37493357 · one of two readings recorded this

  • Median percent change in urinary glyphosate, conventional to organic diet

    decreases, p = 0.01

    Exclude participants missing ≥4 samples or who did not turn in Food Log for either week d | −18.7 (−47.7, 17.5) | −26.8 (−43.1, −16.8) | −11.0 (−47.7, 30.2) | 0.04 | <0.01 | 0.66

    PMID 37493357 · one of two readings recorded this

  • Median percent change in urinary glyphosate, conventional to organic diet

    decreases, p = 0.01

    Exclude participants who did not turn in Food Log for either week c | −19.5 (−42.5, 15.7) | −29.1 (−37.4, −17.0) | −11.0 (−47.7, 30.2) | 0.04 | <0.01 | 0.66

    PMID 37493357 · one of two readings recorded this

  • Median percent change in urinary glyphosate, conventional to organic diet

    decreases, p = 0.06

    All participants b | −18.4 (−37.4, 29.8) | −24.2 (−37.4, −8.8) | 1.4 (−41.9, 43.0) | 0.17 | 0.06 | 0.83

    PMID 37493357 · one of two readings recorded this

  • Median percent change in urinary glyphosate, conventional to organic diet

    no effect, p = 0.82

    Exclude participants missing ≥4 samples from either week c | −17.7 (−37.4, 29.8) | −22.3 (−37.4, −8.8) | 1.4 (−41.9, 43.0) | 0.18 | 0.09 | 0.82

    PMID 37493357 · one of two readings recorded this

  • Median percent change in urinary glyphosate, conventional to organic diet

    no effect, p = 0.66

    Exclude participants missing ≥4 samples or who did not turn in Food Log for either week d | −18.7 (−47.7, 17.5) | −26.8 (−43.1, −16.8) | −11.0 (−47.7, 30.2) | 0.04 | <0.01 | 0.66

    PMID 37493357 · one of two readings recorded this

  • Median percent change in urinary glyphosate, conventional to organic diet

    no effect, p = 0.66

    Exclude participants who did not turn in Food Log for either week c | −19.5 (−42.5, 15.7) | −29.1 (−37.4, −17.0) | −11.0 (−47.7, 30.2) | 0.04 | <0.01 | 0.66

    PMID 37493357 · one of two readings recorded this

  • Median percent change in urinary glyphosate, conventional to organic diet

    no effect, p = 0.83

    All participants b | −18.4 (−37.4, 29.8) | −24.2 (−37.4, −8.8) | 1.4 (−41.9, 43.0) | 0.17 | 0.06 | 0.83

    PMID 37493357 · one of two readings recorded this

  • Participants ordering greater proportion of legumes and grain products in conventional week

    Specifically, 54% of participants ordered a greater proportion of legumes and grain products during the conventional week

    PMID 37493357 · one of two readings recorded this

  • Participants with higher glyphosate during organic week (ITT)

    n = 4

    a greater number of near-field participants had higher glyphosate concentrations during the organic week (n=9) in comparison with far-field participants (n=4)

    PMID 37493357 · one of two readings recorded this

  • Participants with higher glyphosate during organic week (ITT)

    n = 9

    a greater number of near-field participants had higher glyphosate concentrations during the organic week (n=9) in comparison with far-field participants (n=4)

    PMID 37493357 · one of two readings recorded this

  • Urinary glyphosate GM (specific gravity-adjusted), conventional vs organic week

    decreases

    All participants | 76.9 | 0.19 (0.11, 0.30) | 71.8 | 0.17 (0.10, 0.26)

    PMID 37493357 · one of two readings recorded this

  • Urinary glyphosate GM (specific gravity-adjusted), conventional vs organic week

    decreases

    Far-field | 78.9 | 0.18 (0.11, 0.31) | 68.4 | 0.14 (0.10, 0.23)

    PMID 37493357 · one of two readings recorded this

  • Urinary glyphosate GM (specific gravity-adjusted), conventional vs organic week

    no effect

    Near-field | 75.0 | 0.21 (0.12, 0.29) | 75.0 | 0.20 (0.12, 0.27)

    PMID 37493357 · one of two readings recorded this

  • Urinary glyphosate, near-field vs far-field participants

    no effect, p = 0.5

    conventional week: 0.21 vs. 0.18μg/L, p=0.50

    PMID 37493357 · one of two readings recorded this

  • Urinary glyphosate, near-field vs far-field participants

    no effect, p = 0.16

    organic week: 0.20 vs. 0.14μg/L, p=0.16

    PMID 37493357 · one of two readings recorded this

  • Non-detectable urinary AMPA fraction

    non-detectable urinary glyphosate (34.3%) and AMPA (23.1%) concentrations were replaced with the LOD/√2 before inferential analyses

    PMID 39374760 · one of two readings recorded this

  • Non-detectable urinary glyphosate fraction

    non-detectable urinary glyphosate (34.3%) and AMPA (23.1%) concentrations were replaced with the LOD/√2 before inferential analyses

    PMID 39374760 · one of two readings recorded this

  • Urinary AMPA by dietary factors

    no effect

    No dietary factors in the primary or subcategories were significantly associated with AMPA concentrations

    PMID 39374760 · one of two readings recorded this

  • Urinary AMPA by season

    no effect

    No significant differences across seasons were observed for AMPA concentrations

    PMID 39374760 · one of two readings recorded this

  • Urinary AMPA by sociodemographic factors

    decreases

    Similarly, participants who were unemployed, single, and had lower education attainment had lower AMPA levels

    PMID 39374760 · one of two readings recorded this

  • Urinary AMPA, creatinine-adjusted pregnancy-averaged median

    The creatinine-adjusted pregnancy-averaged median (IQR) concentrations of glyphosate and AMPA were 0.36 (0.35) ng/mL and 0.37 (0.33) ng/mL, respectively (Table 2)

    PMID 39374760 · one of two readings recorded this

  • Urinary glyphosate by season, median

    decreases

    slightly lower levels observed in the summer (median [IQR]: 0.30 [0.33] compared to the winter (0.35 [0.42])

    PMID 39374760 · one of two readings recorded this

  • Urinary glyphosate by season, median

    slightly lower levels observed in the summer (median [IQR]: 0.30 [0.33] compared to the winter (0.35 [0.42])

    PMID 39374760 · one of two readings recorded this

  • Urinary glyphosate by sociodemographic factors

    decreases

    Specifically, participants who were younger, obese, on public insurance, single, or had lower educational attainment had lower glyphosate levels

    PMID 39374760 · one of two readings recorded this

  • Urinary glyphosate, creatinine-adjusted pregnancy-averaged median

    The creatinine-adjusted pregnancy-averaged median (IQR) concentrations of glyphosate and AMPA were 0.36 (0.35) ng/mL and 0.37 (0.33) ng/mL, respectively (Table 2)

    PMID 39374760 · one of two readings recorded this

  • Urinary glyphosate difference across four seasons, Kruskal-Wallis

    modulates, p = 0.052

    A Kruskal-Wallis test revealed a statistically significant difference by season (H (3) = 7.69, P = 0.052)

    PMID 39374760 · one of two readings recorded this

  • Urinary glyphosate, percent change per 10% increase in dietary intake

    no effect

    A positive association was observed for eggs but did not reach statistical significance (1.28, 95% CI: −0.31, 2.90)

    PMID 39374760 · one of two readings recorded this

  • Urinary glyphosate, percent change per 10% increase in dietary intake

    no effect

    non-whole/refined grains (0.54, 95% CI: −0.54, 1.63)

    PMID 39374760 · one of two readings recorded this

  • Urinary glyphosate, percent change per 10% increase in dietary intake

    increases

    increased intake of nuts and seeds was associated with significantly higher glyphosate levels (percent change per 10% increase in intake [95% CI]: 1.66 [0.62, 2.71], Figure 1)

    PMID 39374760 · one of two readings recorded this

  • Urinary glyphosate, percent change per 10% increase in dietary intake

    increases

    whole grains (2.62, 95% CI: 0.88, 4.39)

    PMID 39374760 · one of two readings recorded this

  • Urinary glyphosate, winter versus summer pairwise comparison

    decreases, p = 0.022

    follow-up pairwise comparisons indicating only a significant difference between winter and summer (p=0.022)

    PMID 39374760 · one of two readings recorded this

  • CLD risk, AMPA Q4 vs quartiles 1-3 combined (exploratory)

    no effect

    nor for AMPA and CLD (OR = 1.84)

    PMID 39653658 · one of two readings recorded this

  • CLD risk, glyphosate, AMPA and PPA as continuous variables

    increases, p = 0.0001

    the risk of CLD increased in a linear fashion with increasing levels of glyphosate, and with increasing levels of AMPA and PPA (p <.0001 for each compound

    PMID 39653658 · one of two readings recorded this

  • CLD risk, glyphosate Q4 vs quartiles 1-3 combined (exploratory)

    no effect

    we found no statistically significant odds ratios for glyphosate (OR = 0.94 and 1.19 for CLD and HCC, respectively)

    PMID 39653658 · one of two readings recorded this

  • CLD risk, PPA Q4 vs quartiles 1-3 combined (exploratory)

    increases

    For PPA, the odds of both CLD (OR = 2.32, 95% CI 1.58–3.40)

    PMID 39653658 · one of two readings recorded this

  • CLD risk trend across AMPA quartiles

    no effect, p = 0.1803

    p value for trend | 0.1803 | 0.0017

    PMID 39653658 · one of two readings recorded this

  • CLD risk trend across glyphosate quartiles

    increases, p = 0.0004

    p value for trend | 0.0004 | 0.0348

    PMID 39653658 · one of two readings recorded this

  • CLD risk trend across PPA quartiles

    increases, p = 0.0001

    p value for trend | <0.0001 | 0.0003

    PMID 39653658 · one of two readings recorded this

  • CLD risk, urinary AMPA Q2 vs Q1

    no effect

    Q2 (7.6–31.9 nM) | 10 (58.8%) | 5 (29.4%) | 0.54 (0.17–1.73) | 2 (11.8%) | 0.54 (0.11–2.54)

    PMID 39653658 · one of two readings recorded this

  • CLD risk, urinary AMPA Q3 vs Q1

    no effect

    Q3 (32.0–48.4 nM) | 10 (45.5%) | 5 (22.7%) | 0.54 (0.17–1.73) | 7 (31.8%) | 1.70 (0.63–4.60)

    PMID 39653658 · one of two readings recorded this

  • CLD risk, urinary AMPA Q4 vs Q1

    no effect

    Q4 (48.5–167.7 nM) | 11 (23.4%) | 18 (38.3%) | 1.77 (0.79–3.95) | 18 (38.3%) | 3.97 (1.80–8.75)

    PMID 39653658 · one of two readings recorded this

  • CLD risk, urinary glyphosate Q2 vs Q1

    no effect

    Q2 (4.1–15.5 nM) | 57 (51.8%) | 41 (37.3%) | 0.72 (0.41–1.24) | 12 (10.9%) | 0.39 (0.17–0.88)

    PMID 39653658 · one of two readings recorded this

  • CLD risk, urinary glyphosate Q3 vs Q1

    decreases

    Q3 (15.6–26.8 nM) | 60 (48.0%) | 29 (23.2%) | 0.48 (0.26–0.86) | 36 (28.8%) | 1.17 (0.62–2.20)

    PMID 39653658 · one of two readings recorded this

  • CLD risk, urinary glyphosate upper quartile (Q4) vs Q1

    increases, p = 0.0004, n = 475

    Glyphosate exposure shows a significant trend for CLD risk, with an OR of 1.47 (p =.0004, 95% CI 0.89–2.42) in the upper quartile

    PMID 39653658 · one of two readings recorded this

  • CLD risk, urinary PPA Q2 vs Q1

    no effect

    Q2 (36.3–361.9 nM) | 61 (53.5%) | 31 (27.2%) | 0.57 (0.32–1.01) | 22 (19.3%) | 1.60 (0.75–3.41)

    PMID 39653658 · one of two readings recorded this

  • CLD risk, urinary PPA Q3 vs Q1

    no effect

    Q3 (362.0–1167 nM) | 62 (48.8%) | 39 (30.7%) | 0.72 (0.42–1.25) | 26 (20.5%) | 1.86 (0.89–3.89)

    PMID 39653658 · one of two readings recorded this

  • CLD risk, urinary PPA Q4 vs Q1

    increases, p = 0.0001

    an OR of 1.93 for CLD and 3.85 for HCC in the upper quartile (p <.0001, 95% CI 1.13–3.12 and p =.0003, 95% CI 1.94–7.65, respectively)

    PMID 39653658 · one of two readings recorded this

  • Correlation among urinary glyphosate, AMPA and PPA

    increases, p = 0.0001, n = 591

    The urinary levels of the three compounds were highly correlated, particularly PPA with glyphosate and AMPA (r > 0.50 and p <.0001 for both comparison)

    PMID 39653658 · one of two readings recorded this

  • Declined participation, CLD patients

    were 7.8% of HCC cases, 15.8% of CLD patients, and 1.1% of hospital controls

    PMID 39653658 · one of two readings recorded this

  • Declined participation, HCC cases

    were 7.8% of HCC cases, 15.8% of CLD patients, and 1.1% of hospital controls

    PMID 39653658 · one of two readings recorded this

  • Declined participation, hospital controls

    were 7.8% of HCC cases, 15.8% of CLD patients, and 1.1% of hospital controls

    PMID 39653658 · one of two readings recorded this

  • HCC risk, AMPA continuous regression coefficient

    no effect, p = 0.41

    failed to reach statistical significance (p =.065, 0.41, and 0.28 for glyphosate, AMPA, PPA, respectively

    PMID 39653658 · one of two readings recorded this

  • HCC risk, AMPA Q4 vs quartiles 1-3 combined (exploratory)

    increases

    for AMPA, there was an elevated odds ratio for HCC (OR = 3.94, 95% CI 1.80–8.65)

    PMID 39653658 · one of two readings recorded this

  • HCC risk, glyphosate continuous regression coefficient

    no effect, p = 0.065

    failed to reach statistical significance (p =.065, 0.41, and 0.28 for glyphosate, AMPA, PPA, respectively

    PMID 39653658 · one of two readings recorded this

  • HCC risk, glyphosate Q4 vs quartiles 1-3 combined (exploratory)

    no effect

    we found no statistically significant odds ratios for glyphosate (OR = 0.94 and 1.19 for CLD and HCC, respectively)

    PMID 39653658 · one of two readings recorded this

  • HCC risk, PPA continuous regression coefficient

    no effect, p = 0.28

    failed to reach statistical significance (p =.065, 0.41, and 0.28 for glyphosate, AMPA, PPA, respectively

    PMID 39653658 · one of two readings recorded this

  • HCC risk, PPA Q4 vs quartiles 1-3 combined (exploratory)

    increases

    HCC (OR = 2.60, 95% CI 1.63–4.14)

    PMID 39653658 · one of two readings recorded this

  • HCC risk trend across AMPA quartiles

    increases, p = 0.0017

    p value for trend | 0.1803 | 0.0017

    PMID 39653658 · one of two readings recorded this

  • HCC risk trend across glyphosate quartiles

    unclear, p = 0.0348

    p value for trend | 0.0004 | 0.0348

    PMID 39653658 · one of two readings recorded this

  • HCC risk trend across PPA quartiles

    increases, p = 0.0003

    p value for trend | <0.0001 | 0.0003

    PMID 39653658 · one of two readings recorded this

  • HCC risk, urinary AMPA Q2 vs Q1

    no effect

    Q2 (7.6–31.9 nM) | 10 (58.8%) | 5 (29.4%) | 0.54 (0.17–1.73) | 2 (11.8%) | 0.54 (0.11–2.54)

    PMID 39653658 · one of two readings recorded this

  • HCC risk, urinary AMPA Q3 vs Q1

    no effect

    Q3 (32.0–48.4 nM) | 10 (45.5%) | 5 (22.7%) | 0.54 (0.17–1.73) | 7 (31.8%) | 1.70 (0.63–4.60)

    PMID 39653658 · one of two readings recorded this

  • HCC risk, urinary AMPA Q4 vs Q1

    increases, p = 0.0017

    AMPA is significantly associated with HCC, with the upper quartile exhibiting an OR of 3.97 (p =.0017, 95% CI 1.80–8.75)

    PMID 39653658 · one of two readings recorded this

  • HCC risk, urinary glyphosate Q2 vs Q1

    decreases

    Q2 (4.1–15.5 nM) | 57 (51.8%) | 41 (37.3%) | 0.72 (0.41–1.24) | 12 (10.9%) | 0.39 (0.17–0.88)

    PMID 39653658 · one of two readings recorded this

  • HCC risk, urinary glyphosate Q3 vs Q1

    no effect

    Q3 (15.6–26.8 nM) | 60 (48.0%) | 29 (23.2%) | 0.48 (0.26–0.86) | 36 (28.8%) | 1.17 (0.62–2.20)

    PMID 39653658 · one of two readings recorded this

  • HCC risk, urinary glyphosate Q4 vs Q1

    no effect

    Q4 (26.9–172.4 nM) | 60 (33.3%) | 88 (48.9%) | 1.47 (0.89–2.42) | 32 (17.8%) | 1.04 (0.58–1.87)

    PMID 39653658 · one of two readings recorded this

  • HCC risk, urinary PPA Q2 vs Q1

    no effect

    Q2 (36.3–361.9 nM) | 61 (53.5%) | 31 (27.2%) | 0.57 (0.32–1.01) | 22 (19.3%) | 1.60 (0.75–3.41)

    PMID 39653658 · one of two readings recorded this

  • HCC risk, urinary PPA Q3 vs Q1

    no effect

    Q3 (362.0–1167 nM) | 62 (48.8%) | 39 (30.7%) | 0.72 (0.42–1.25) | 26 (20.5%) | 1.86 (0.89–3.89)

    PMID 39653658 · one of two readings recorded this

  • HCC risk, urinary PPA Q4 vs Q1

    increases, p = 0.0003

    an OR of 1.93 for CLD and 3.85 for HCC in the upper quartile (p <.0001, 95% CI 1.13–3.12 and p =.0003, 95% CI 1.94–7.65, respectively)

    PMID 39653658 · one of two readings recorded this

  • Median urinary glyphosate in hospital controls, central region

    Specifically, hospital controls in the northern region had a median glyphosate level of 43 nM, compared to 25 nM in the central region and 27 nM in the northeast.

    PMID 39653658 · one of two readings recorded this

  • Median urinary glyphosate in hospital controls, northeast region

    Specifically, hospital controls in the northern region had a median glyphosate level of 43 nM, compared to 25 nM in the central region and 27 nM in the northeast.

    PMID 39653658 · one of two readings recorded this

  • Median urinary glyphosate in hospital controls, northern region

    increases

    Specifically, hospital controls in the northern region had a median glyphosate level of 43 nM, compared to 25 nM in the central region and 27 nM in the northeast.

    PMID 39653658 · one of two readings recorded this

  • Urinary AMPA, CLD vs hospital controls

    increases, p = 0.02, n = 591

    its level in CLD was also higher than in hospital controls (p =.02)

    PMID 39653658 · one of two readings recorded this

  • Urinary AMPA, HCC vs other groups

    increases, p = 0.0001, n = 591

    The highest level of AMPA was in the HCC group (p <.0001

    PMID 39653658 · one of two readings recorded this

  • Urinary AMPA, mean (min-max)

    increases, n = 591

    AMPA (nM mean [min–max]) | 70.0 (nd–167.93) | 107 (nd–415.1) | 285 (nd–1977.2)

    PMID 39653658 · one of two readings recorded this

  • Urinary glyphosate, CLD vs other groups

    increases, n = 591

    Higher levels of urinary glyphosate were observed in CLD patients compared to all other groups, while the levels in HCC did not significantly differ from hospital controls

    PMID 39653658 · one of two readings recorded this

  • Urinary glyphosate, males vs females in CLD

    increases

    where males had over 2‐fold higher levels of glyphosate compared to their female counterparts

    PMID 39653658 · one of two readings recorded this

  • Urinary glyphosate, mean (min-max)

    increases, n = 591

    Glyphosate (nM mean [min–max]) | 38.1 (nd–291.50) | 120 (nd–4711.90) | 40.7 (nd–161.80)

    PMID 39653658 · one of two readings recorded this

  • Urinary phosphoric acid (PPA), mean (min-max)

    increases, n = 591

    PPA (nM, mean [min–max]) | 2790 (36.05–18,526) | 5340 (19.23–22,641) | 4670 (41.22–15,019)

    PMID 39653658 · one of two readings recorded this

  • Urinary PPA, HCC and CLD vs hospital controls

    increases, p = 0.0001, n = 591

    Levels of PPA were higher in the HCC and CLD groups, relative to hospital controls (p <.0001 for each comparison)

    PMID 39653658 · one of two readings recorded this

  • Age by urinary glyphosate group

    increases, p = 0.001, n = 4740

    Age, years | 723,907,169 | 0 | 45.88 (44.86,46.90) | 48.05 (47.11,48.98) | 0.001

    PMID 40155766 · one of two readings recorded this

  • All-cause mortality, high vs low urinary glyphosate group

    increases, p = 0.001, n = 4740

    High group | 9,972.28 | 152 | 15.24 | 1.77 (1.28-2,44) < 0.001 | 1.38 (0.98–1.95) 0.066 | 1.50 (1.05–2.14) 0.026

    PMID 40155766 · one of two readings recorded this

  • All-cause mortality, high vs low urinary glyphosate group

    unclear, p = 0.066, n = 4740

    High group | 9,972.28 | 152 | 15.24 | 1.77 (1.28-2,44) < 0.001 | 1.38 (0.98–1.95) 0.066 | 1.50 (1.05–2.14) 0.026

    PMID 40155766 · one of two readings recorded this

  • All-cause mortality, high vs low urinary glyphosate group

    increases, n = 4740

    In Model 3, the corresponding HRs for all-cause mortality was 1.50 (95% CI, 1.05–2.14)

    PMID 40155766 · one of two readings recorded this

  • All-cause mortality, log likelihood ratio test of two-piecewise vs standard Cox model

    no effect, p = 0.344, n = 4740

    Log likelihood ratio | 0.344 | 0.019

    PMID 40155766 · one of two readings recorded this

  • All-cause mortality per 1 ng/mL urinary glyphosate

    increases, n = 4740

    In the unadjusted model, the all-cause mortality increased by 49% with each 1 ng/mL increase in the urinary GLY (HR 1.49, 95% CI 1.24–1.79)

    PMID 40155766 · one of two readings recorded this

  • All-cause mortality per 1 ng/mL urinary glyphosate

    increases, n = 4740

    Model 2 (HR 1.31, 95% CI 0.99–1.71)

    PMID 40155766 · one of two readings recorded this

  • All-cause mortality per 1 ng/mL urinary glyphosate

    increases, p = 0.008, n = 4740

    Continuous | 19,092.33 | 238 | 12.47 | 1.49 (1.24–1.79) < 0.001 | 1.31 (0.99–1.71) 0.055 | 1.40 (1.09–1.80) 0.008

    PMID 40155766 · one of two readings recorded this

  • All-cause mortality per urinary glyphosate, females

    increases

    (HR 1.59, 95% CI 1.20–2.10)

    PMID 40155766 · one of two readings recorded this

  • All-cause mortality rate

    n = 238

    Continuous | 19,092.33 | 238 | 12.47 | 1.49 (1.24–1.79) < 0.001 | 1.31 (0.99–1.71) 0.055 | 1.40 (1.09–1.80) 0.008

    PMID 40155766 · one of two readings recorded this

  • All-cause mortality rate

    n = 152

    High group | 9,972.28 | 152 | 15.24 | 1.77 (1.28-2,44) < 0.001 | 1.38 (0.98–1.95) 0.066 | 1.50 (1.05–2.14) 0.026

    PMID 40155766 · one of two readings recorded this

  • All-cause mortality rate

    n = 86

    Low group | 8,761.60 | 86 | 9.82 | reference | reference | reference

    PMID 40155766 · one of two readings recorded this

  • All-cause mortality, standard Cox model per ng/mL urinary glyphosate (threshold analysis)

    increases, p = 0.014, n = 4740

    Fitting by standard Cox proportional hazards model | 1.47 (1.08, 2.00) 0.014 | 1.41 (0.86, 2.30) 0.176

    PMID 40155766 · one of two readings recorded this

The whole record — 339 rows